Company page

Newamsterdam Pharma Company N.v.

Newamsterdam Pharma Company N.V. is a publicly traded company listed under the ticker NAMS in the American market. With a market capitalization of approximately $3.7 billion, the company focuses on developing innovative pharmaceutical solutions. Their commitment to advancing healthcare is reflected in their ongoing research and development efforts.